|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM303816597 |
003 |
DE-627 |
005 |
20231225113631.0 |
007 |
cr uuu---uuuuu |
008 |
231225s2020 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.2144/btn-2019-0092
|2 doi
|
028 |
5 |
2 |
|a pubmed24n1012.xml
|
035 |
|
|
|a (DE-627)NLM303816597
|
035 |
|
|
|a (NLM)31779479
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Webb, Martyn
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Methodology for the at-home collection of urine samples for prostate cancer detection
|
264 |
|
1 |
|c 2020
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 07.12.2020
|
500 |
|
|
|a Date Revised 14.12.2020
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Urine from patients with prostate cancer (PCa) contains gene transcripts that have been used for PCa diagnosis and prognosis. Historically, patient urine samples have been collected after a digital rectal examination of the prostate, which was thought necessary to boost the levels of prostatic secretions in the urine. We herein describe methodology that allows urine to be collected by patients at home and then posted to a laboratory for analysis. RNA yields and quality were comparable to those for post digital rectal examination urine, and there was improved sensitivity for the detection of TMPRSS2:ERG transcripts by RT-PCR. The At-Home collection protocol has opened up the potential to perform large-scale PCa studies without the inconvenience, cost, discomfort and expense of patients having to visit the clinic
|
650 |
|
4 |
|a Controlled Clinical Trial
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
4 |
|a biomarker
|
650 |
|
4 |
|a cancer
|
650 |
|
4 |
|a diagnosis
|
650 |
|
4 |
|a home-screening
|
650 |
|
4 |
|a prognosis
|
650 |
|
4 |
|a prostate
|
650 |
|
4 |
|a urine
|
650 |
|
7 |
|a RNA
|2 NLM
|
650 |
|
7 |
|a 63231-63-0
|2 NLM
|
700 |
1 |
|
|a Manley, Kate
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Olivan, Mireia
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Guldvik, Ingrid
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Palczynska, Malgorzata
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Hurst, Rachel
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Connell, Shea P
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Mills, Ian G
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Brewer, Daniel S
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Mills, Robert
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Cooper, Colin S
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Clark, Jeremy
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t BioTechniques
|d 1988
|g 68(2020), 2 vom: 01. Feb., Seite 65-71
|w (DE-627)NLM012627046
|x 1940-9818
|7 nnns
|
773 |
1 |
8 |
|g volume:68
|g year:2020
|g number:2
|g day:01
|g month:02
|g pages:65-71
|
856 |
4 |
0 |
|u http://dx.doi.org/10.2144/btn-2019-0092
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_21
|
912 |
|
|
|a GBV_ILN_22
|
912 |
|
|
|a GBV_ILN_39
|
912 |
|
|
|a GBV_ILN_40
|
912 |
|
|
|a GBV_ILN_50
|
912 |
|
|
|a GBV_ILN_60
|
912 |
|
|
|a GBV_ILN_62
|
912 |
|
|
|a GBV_ILN_65
|
912 |
|
|
|a GBV_ILN_70
|
912 |
|
|
|a GBV_ILN_99
|
912 |
|
|
|a GBV_ILN_121
|
912 |
|
|
|a GBV_ILN_130
|
912 |
|
|
|a GBV_ILN_227
|
912 |
|
|
|a GBV_ILN_350
|
912 |
|
|
|a GBV_ILN_618
|
912 |
|
|
|a GBV_ILN_640
|
912 |
|
|
|a GBV_ILN_754
|
912 |
|
|
|a GBV_ILN_2001
|
912 |
|
|
|a GBV_ILN_2002
|
912 |
|
|
|a GBV_ILN_2003
|
912 |
|
|
|a GBV_ILN_2005
|
912 |
|
|
|a GBV_ILN_2006
|
912 |
|
|
|a GBV_ILN_2007
|
912 |
|
|
|a GBV_ILN_2008
|
912 |
|
|
|a GBV_ILN_2009
|
912 |
|
|
|a GBV_ILN_2010
|
912 |
|
|
|a GBV_ILN_2012
|
912 |
|
|
|a GBV_ILN_2015
|
912 |
|
|
|a GBV_ILN_2018
|
912 |
|
|
|a GBV_ILN_2023
|
912 |
|
|
|a GBV_ILN_2035
|
912 |
|
|
|a GBV_ILN_2040
|
912 |
|
|
|a GBV_ILN_2060
|
912 |
|
|
|a GBV_ILN_2099
|
912 |
|
|
|a GBV_ILN_2105
|
912 |
|
|
|a GBV_ILN_2121
|
912 |
|
|
|a GBV_ILN_2470
|
951 |
|
|
|a AR
|
952 |
|
|
|d 68
|j 2020
|e 2
|b 01
|c 02
|h 65-71
|